April 26th, 2008, by Digital Davo | clinical trials, topicals
A seemingly new topical treatment for rosacea is being trialled by Dow Pharmaceutical Sciences. The product is being evaluated firstly for the number of inflammatory lesions and global severity, and secondly for redness. This, along with the trial lasting 12 weeks, and the large size of the trial leads me to guess that IDP-115 is a metronidazole or azelaic acid variant.
Google hasn’t found any clues …
April 18th, 2008, by Digital Davo | clinical trials, natural remedies
Laura Kopec from Kopec Naturals is offering free 1 oz samples of their Rosacea Relief product. According to their web site, Rosacea Relief contains, “Proprietary blend of Barbadensis vulgaris (aloe vera), Hamamelis virginiana (witch hazel), Melaleuca alternifolia (tea tree) oil, and other natural ingredients.” See her post at the Rosacea Support Forum - Free 1 oz Sample of Rosacea Relief for more information. …
April 11th, 2008, by Digital Davo | clinical trials, natural remedies
Just posted to the Rosacea Support Forum is a request for rosacea sufferers who are interested in a new series of aloe vera capsules and gel. See Aloe vera company seeks participants for Rosacea study for more information. Aloemaxx Health Systems Inc, is a retailer of organic, non-toxic aloe vera products. Through the cooperation of rosacea-support.org, Aloemaxx is seeking twelve participants to take …
December 30th, 2007, by Digital Davo | clinical trials, papules & pustules
A new trial has just been posted that will be looking at how Pyratine 6 (a variant of Kinetin) treats the papules & pustules, redness and visible blood vessels of rosacea.
From Clinical Trial NCT00580723: Effects of PRK 124 Lotion in Acne Rosacea
The purpose of this open-label study is to determine the tolerance and efficacy of twice-daily application of PRK 124 (Pyratine-6)(0.125%) moisturizing lotion …
November 1st, 2007, by Digital Davo | clinical trials, in the news, melanotan
Getting some press in Australia currently is a story about a trial starting today in Melbourne. The trial will assess the efficacy of CUV1647 (also known as melanotan) to protect against skin cancer in patients who have had organ transplants. Patients who have received organ transplants are at a much higher risk of contracting skin cancer because of the immune suppressive drugs that they …
|
|
|
|
|
|